Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors

Nicolas Sluis-Cremer, Gilda Tachedjian

Research output: Contribution to journalArticleResearchpeer-review

130 Citations (Scopus)


The non-nucleoside reverse transcriptase (RT) inhibitors (NNRTIs) are a therapeutic class of compounds that are routinely used, in combination with other antiretroviral drugs, to treat HIV-1 infection. NNRTIs primarily block HIV-1 replication by preventing RT from completing reverse transcription of the viral single-stranded RNA genome into DNA. However, some NNRTIs, such as efavirenz, have been shown to inhibit the late stages of HIV-1 replication by interfering with HIV-1 Gag-Pol polyprotein processing, while others, such as the pyrimidinediones, have been shown to inhibit both HIV-1 RT-mediated reverse transcription and HIV-1/HIV-2 viral entry. Accordingly, in this review we describe the multiple mechanisms by which NNRTIs inhibit HIV-1 reverse transcription (and in some cases HIV-2 reverse transcription) and other key steps involved in HIV-1/HIV-2 replication.
Original languageEnglish
Pages (from-to)147 - 156
Number of pages10
JournalVirus Research
Issue number1-2
Publication statusPublished - 2008

Cite this